Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Dry Eye Disease Diagnostics & Treatment Market


4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis


5. Key Insights

5.1. Technological Advancements

5.2. Pipeline Analysis

5.3. Disease Prevalence & Incidence Rate globally with key countries

5.4. Key Mergers & Acquisitions

5.5. COVID-19 Pandemics Impact on Industry (short / mid / long term impact)


6. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Type, 2018–2030

6.3.1. Diagnostic Test

6.3.1.1. Schirmer’s Test

6.3.1.2. Corneal Staining

6.3.1.3. Tear Break-up Time (TBUT)

6.3.1.4. Optical Coherence Tomography (OCT)

6.3.1.5. Tear Film Stability Analysis

6.3.1.6. Tear Osmolarity

6.3.1.7. Others

6.3.2. Treatment

6.3.2.1. Artificial Tears

6.3.2.2. Anti-inflammatory

6.3.2.2.1. Cyclosporine

6.3.2.2.2. Corticosteroid

6.3.2.2.3. Others

6.3.2.3. Punctal Plugs

6.3.2.4. Secretagogue

6.3.2.5. Others

6.4. Market Attractiveness Analysis, by Type


7. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Disease

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Disease, 2018–2030

7.3.1. Evaporative Dry Eye Syndrome

7.3.2. Aqueous Dry Eye Syndrome

7.4. Market Attractiveness Analysis, by Disease


8. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Country/Region


9. North America Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Market Value Forecast, by Type, 2018–2030

9.2.1. Diagnostic Test

9.2.1.1. Schirmer’s Test

9.2.1.2. Corneal Staining

9.2.1.3. Tear Break-up Time (TBUT)

9.2.1.4. Optical Coherence Tomography (OCT)

9.2.1.5. Tear Film Stability Analysis

9.2.1.6. Tear Osmolarity

9.2.1.7. Others

9.2.2. Treatment

9.2.2.1. Artificial Tears

9.2.2.2. Anti-inflammatory

9.2.2.2.1. Cyclosporine

9.2.2.2.2. Corticosteroid

9.2.2.2.3. Others

9.2.2.3. Punctal Plugs

9.2.2.4. Secretagogue

9.2.2.5. Others

9.3. Market Value Forecast, by Disease, 2018–2030

9.3.1. Evaporative Dry Eye Syndrome

9.3.2. Aqueous Dry Eye Syndrome

9.4. Market Value Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Type

9.5.2. By Disease

9.5.3. By Country


10. Europe Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Type, 2018–2030

10.2.1. Diagnostic Test

10.2.1.1. Schirmer’s Test

10.2.1.2. Corneal Staining

10.2.1.3. Tear Break-up Time (TBUT)

10.2.1.4. Optical Coherence Tomography (OCT)

10.2.1.5. Tear Film Stability Analysis

10.2.1.6. Tear Osmolarity

10.2.1.7. Others

10.2.2. Treatment

10.2.2.1. Artificial Tears

10.2.2.2. Anti-inflammatory

10.2.2.2.1. Cyclosporine

10.2.2.2.2. Corticosteroid

10.2.2.2.3. Others

10.2.2.3. Punctal Plugs

10.2.2.4. Secretagogue

10.2.2.5. Others

10.3. Market Value Forecast, by Disease, 2018–2030

10.3.1. Evaporative Dry Eye Syndrome

10.3.2. Aqueous Dry Eye Syndrome

10.4. Market Value Forecast, by Country/Sub-region, 2018–2030

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Market Attractiveness Analysis

10.5.1. By Type

10.5.2. By Disease

10.5.3. By Country/Sub-region

11. Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Type, 2018–2030

11.2.1. Diagnostic Test

11.2.1.1. Schirmer’s Test

11.2.1.2. Corneal Staining

11.2.1.3. Tear Break-up Time (TBUT)

11.2.1.4. Optical Coherence Tomography (OCT)

11.2.1.5. Tear Film Stability Analysis

11.2.1.6. Tear Osmolarity

11.2.1.7. Others

11.2.2. Treatment

11.2.2.1. Artificial Tears

11.2.2.2. Anti-inflammatory

11.2.2.2.1. Cyclosporine

11.2.2.2.2. Corticosteroid

11.2.2.2.3. Others

11.2.2.3. Punctal Plugs

11.2.2.4. Secretagogue

11.2.2.5. Others

11.3. Market Value Forecast, by Disease, 2018–2030

11.3.1. Evaporative Dry Eye Syndrome

11.3.2. Aqueous Dry Eye Syndrome

11.4. Market Value Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Market Attractiveness Analysis

11.5.1. By Type

11.5.2. By Disease

11.5.3. By Country/Sub-region

12. Latin America Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Type, 2018–2030

12.2.1. Diagnostic Test

12.2.1.1. Schirmer’s Test

12.2.1.2. Corneal Staining

12.2.1.3. Tear Break-up Time (TBUT)

12.2.1.4. Optical Coherence Tomography (OCT)

12.2.1.5. Tear Film Stability Analysis

12.2.1.6. Tear Osmolarity

12.2.1.7. Others

12.2.2. Treatment

12.2.2.1. Artificial Tears

12.2.2.2. Anti-inflammatory

12.2.2.2.1. Cyclosporine

12.2.2.2.2. Corticosteroid

12.2.2.2.3. Others

12.2.2.3. Punctal Plugs

12.2.2.4. Secretagogue

12.2.2.5. Others

12.3. Market Value Forecast, by Disease, 2018–2030

12.3.1. Evaporative Dry Eye Syndrome

12.3.2. Aqueous Dry Eye Syndrome

12.4. Market Value Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Market Attractiveness Analysis

12.5.1. By Type

12.5.2. By Disease

12.5.3. By Country/Sub-region

13. Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Type, 2018–2030

13.2.1. Diagnostic Test

13.2.1.1. Schirmer’s Test

13.2.1.2. Corneal Staining

13.2.1.3. Tear Break-up Time (TBUT)

13.2.1.4. Optical Coherence Tomography (OCT)

13.2.1.5. Tear Film Stability Analysis

13.2.1.6. Tear Osmolarity

13.2.1.7. Others

13.2.2. Treatment

13.2.2.1. Artificial Tears

13.2.2.2. Anti-inflammatory

13.2.2.2.1. Cyclosporine

13.2.2.2.2. Corticosteroid

13.2.2.2.3. Others

13.2.2.3. Punctal Plugs

13.2.2.4. Secretagogue

13.2.2.5. Others

13.3. Market Value Forecast, by Disease, 2018–2030

13.3.1. Evaporative Dry Eye Syndrome

13.3.2. Aqueous Dry Eye Syndrome

13.4. Market Value Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Market Attractiveness Analysis

13.5.1. By Type

13.5.2. By Disease

13.5.3. By Country/Sub-region


14. Competition Landscape

14.1. Market Player - Competition Matrix (by tier and size of companies)

14.2. Market Share/Position Analysis, by Company, 2019

14.3. Competitive Business Strategies

14.4. Company Profiles

14.4.1. Novartis AG

14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.1.2. Company Financials

14.4.1.3. Growth Strategies

14.4.1.4. SWOT Analysis

14.4.2. Allergan plc

14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.2.2. Company Financials

14.4.2.3. Growth Strategies

14.4.2.4. SWOT Analysis

14.4.3. OASIS Medical

14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.3.2. Company Financials

14.4.3.3. Growth Strategies

14.4.3.4. SWOT Analysis

14.4.4. Santen Pharmaceutical Co., Ltd.

14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.4.2. Company Financials

14.4.4.3. Growth Strategies

14.4.4.4. SWOT Analysis

14.4.5. Johnson & Johnson

14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.5.2. Company Financials

14.4.5.3. Growth Strategies

14.4.5.4. SWOT Analysis

14.4.6. Otsuka Pharmaceutical Co., Ltd.

14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.6.2. Company Financials

14.4.6.3. Growth Strategies

14.4.6.4. SWOT Analysis

14.4.7. Advanced Tear Diagnostics

14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.7.2. Company Financials

14.4.7.3. Growth Strategies

14.4.7.4. SWOT Analysis

14.4.8. Tomey Corporation

14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.8.2. Company Financials

14.4.8.3. Growth Strategies

14.4.8.4. SWOT Analysis

14.4.9. Carl Zeiss Meditec AG

14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.9.2. Company Financials

14.4.9.3. Growth Strategies

14.4.9.4. SWOT Analysis

14.4.10. TearLab Corporation

14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.10.2. Company Financials

14.4.10.3. Growth Strategies

14.4.10.4. SWOT Analysis

14.4.11. Bausch Health Companies, Inc.

14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.11.2. Company Financials

14.4.11.3. Growth Strategies

14.4.11.4. SWOT Analysis

14.4.12. RegeneRx (ReGenTree, LLC)

14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.12.2. Company Financials

14.4.12.3. Growth Strategies

14.4.12.4. SWOT Analysis



List of Figures



Figure 01: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Dry Eye Disease Diagnostics & Treatment Market Value Share, by Type, 2019

Figure 03: Global Dry Eye Disease Diagnostics & Treatment Market Value Share, by Disease, 2019

Figure 04: Global Dry Eye Disease Diagnostics & Treatment Market Value Share, by Region, 2019

Figure 05: Global Dry Eye Disease Diagnostics & Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 06: Global Dry Eye Disease Diagnostics & Treatment Market Value Share Analysis, by Diagnostic Test, 2019 and 2030

Figure 07: Global Dry Eye Disease Diagnostics & Treatment Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 08: Global Dry Eye Disease Diagnostics & Treatment Market Value Share Analysis, by Anti-inflammatory, 2019 and 2030

Figure 09: Global Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn), by Diagnostic Test, 2018–2030

Figure 10: Global Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn), by Treatment, 2018–2030

Figure 11: Global Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 12: Global Dry Eye Disease Diagnostics & Treatment Market Value Share Analysis, by Disease, 2019 and 2030

Figure 13: Global Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn), by Evaporative Dry Eye Syndrome, 2018–2030

Figure 14: Global Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn), by Aqueous Dry Eye Syndrome, 2018–2030

Figure 15: Global Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 16: Global Dry Eye Disease Diagnostics & Treatment Market Value Share Analysis, by Region, 2019 and 2030

Figure 17: Global Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Region, 2020–2030

Figure 18: North America Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 19: North America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Country, 2019 and 2030

Figure 20: North America Dry Eye Disease Diagnostics & Treatment Market Attractiveness, by Country, 2020–2030

Figure 21: North America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Type, 2019 and 2030

Figure 22: North America Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 23: North America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Diagnostic Test, 2019 and 2030

Figure 24: North America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Treatment, 2019 and 2030

Figure 25: North America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Anti-inflammatory, 2019 and 2030

Figure 26: North America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030

Figure 27: North America Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 28: Europe Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 29: Europe Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030

Figure 30: Europe Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 31: Europe Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Type, 2019 and 2030

Figure 32: Europe Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 33: Europe Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Diagnostic Test, 2019 and 2030

Figure 34: Europe Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Treatment, 2019 and 2030

Figure 35: Europe Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Anti-inflammatory, 2019 and 2030

Figure 36: Europe Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030

Figure 37: Europe Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 38: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 39: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030

Figure 40: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 41: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Type, 2019 and 2030

Figure 42: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 43: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Diagnostic Test, 2019 and 2030

Figure 44: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Treatment, 2019 and 2030

Figure 45: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Anti-inflammatory, 2019 and 2030

Figure 46: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030

Figure 47: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 48: Latin America Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 49: Latin America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030

Figure 50: Latin America Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 51: Latin America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Type, 2019 and 2030

Figure 52: Latin America Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 53: Latin America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Diagnostic Test, 2019 and 2030

Figure 54: Latin America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Treatment, 2019 and 2030

Figure 55: Latin America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Anti-inflammatory, 2019 and 2030

Figure 56: Latin America Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030

Figure 57: Latin America Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 58: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 59: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030

Figure 60: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 61: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Type, 2019 and 2030

Figure 62: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 63: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Diagnostic Test, 2019 and 2030

Figure 64: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Treatment, 2019 and 2030

Figure 65: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Anti-inflammatory, 2019 and 2030

Figure 66: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030

Figure 67: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Attractiveness Analysis, by Disease, 2020–2030

Figure 68: Market Position/Ranking Analysis, 2019, by Tier and Size of the Company


List of Tables



Table 01: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 02: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 03: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 04: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 05: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 06: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 08: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 09: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 10: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 11: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 12: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 13: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 15: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 16: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 17: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 18: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 19: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 20: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Type, 2018–2030

Table 21: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 22: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 23: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 24: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Disease, 2018–2030

Table 25: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 27: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 28: Latin America Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 29: Latin America Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 30: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 31: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 32: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Type, 2018–2030

Table 33: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 34: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 35: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 36: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Disease, 2018–2030